Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn why balancing short and long term goals leads to steadier progress and fewer stressful financial decisions.
28,657 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Major appliance brands warn buyers to pace big-ticket purchases as demand cools and prices rise. The article surveys ...
Adobe's AI push lifts revenue and unlocks upside for investors as shares hover near $253. This adobe price prediction...
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
mastec (mtz) 150% year momentum drives the rally as the company backs a strong 2026 outlook. Analysts see upside as b...
A new analyst survey shows overwhelming Buy ratings for Amazon, with no Sell calls. The result comes as AWS accelerat...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
NVIDIA posted a record-breaking $75.25 billion in Data Center revenue for its fiscal Q1 2027, a 92% year-over-year su...
Iovance surged this week after robust Q4 results and a Philadelphia manufacturing moat highlighted by a 32 day turnar...
Pinterest faces headwinds after a price-target cut to $27. This story outlines three critical steps that could unlock...
Qualcomm surged in early trading after landing Meta Platforms as a data center customer for its Dragonfly chip, then ...
A prominent contrarian investor has revealed a bold, long-term bet on Microsoft, using December 2028 LEAP calls to ca...